Skip to main content
Premium Trial:

Request an Annual Quote

Fred Hutchinson Center Plans Lab Support, Office Uses for New Building

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Research Center said it will use a newly-acquired building adjacent to its campus in Seattle's South Lake Union section for research support facilities as well as offices — and possibly could expand its lab research space as a result.

"This offers an outstanding opportunity to expand our solid tumor, infectious disease, and immunotherapy research as well as work toward the goal of consolidating all of the Center's research activities onto one campus," Doug Walker, chairman of the Hutchinson Center's board, said in a statement.

The Hutchinson Center paid $36 million to acquire the 177,000-square-foot building, at 1100 Eastlake Ave. E., from the Blume 1100 Partnership, a group of investors led by Seattle developer Bruce Blume, CEO of The Blume Company

The Hutchinson Center said in the statement that it plans to occupy the building in June 2012.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.